UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interferons α and β in cancer: therapeutic opportunities from new insights

Nature reviews. Drug discovery, 2019-03, Vol.18 (3), p.219-234

Borden, Ernest C

2019

Volltextzugriff (PDF)

Interferons at age 50: past, current and future impact on biomedicine

Nature reviews. Drug discovery, 2007-12, Vol.6 (12), p.975-990

2007

Volltextzugriff (PDF)

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

Journal of clinical oncology, 2008-02, Vol.26 (4), p.626-632

2008

Volltextzugriff (PDF)

Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5360-5367

2008

Volltextzugriff (PDF)

Emerging roles of FAM14 family members (G1P3/ISG 6-16 and ISG12/IFI27) in innate immunity and cancer

Journal of interferon & cytokine research, 2011-01, Vol.31 (1), p.173-181

2011

Volltextzugriff (PDF)

Noncanonical Activation of Notch1 Protein by Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Controls Melanoma Cell Proliferation

The Journal of biological chemistry, 2014-03, Vol.289 (12), p.8442-8449

2014

Volltextzugriff (PDF)

Phase II Study of Erlotinib in Patients With Malignant Pleural Mesothelioma: A Southwest Oncology Group Study

Journal of clinical oncology, 2007-06, Vol.25 (17), p.2406-2413

2007

Volltextzugriff (PDF)

Interferons and Their Stimulated Genes in the Tumor Microenvironment

Seminars in oncology, 2014-04, Vol.41 (2), p.156-173

2014

Volltextzugriff (PDF)

Proteomic identification of proteins conjugated to ISG15 in mouse and human cells

Biochemical and biophysical research communications, 2005-10, Vol.336 (2), p.496-506

2005

Volltextzugriff (PDF)

Phase I trials of targeted anticancer drugs: a need to refocus

Nature reviews. Drug discovery, 2012-12, Vol.11 (12), p.889-890

2012

Volltextzugriff (PDF)

Overcoming Resistance to Interferon-Induced Apoptosis of Renal Carcinoma and Melanoma Cells by DNA Demethylation

Journal of clinical oncology, 2006-08, Vol.24 (23), p.3771-3779

2006

Volltextzugriff (PDF)

G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells

The Journal of clinical investigation, 2007-10, Vol.117 (10), p.3107-3117

2007

Volltextzugriff (PDF)

Identification of X-linked Inhibitor of Apoptosis-associated Factor-1 as an Interferon-stimulated Gene That Augments TRAIL Apo2L-induced Apoptosis

The Journal of biological chemistry, 2002-08, Vol.277 (32), p.28504-28511

2002

Volltextzugriff (PDF)

Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands

Nature (London), 2010-10, Vol.467 (7318), p.972-976

2010

Volltextzugriff (PDF)

Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma

Neuro-oncology (Charlottesville, Va.), 2011-06, Vol.13 (6), p.591-599

2011

Volltextzugriff (PDF)

The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon

Journal of translational medicine, 2012-12, Vol.10 (1), p.241-241, Article 241

2012

Volltextzugriff (PDF)

Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: A phase II study of the Southwest Oncology Group (SWOG 9810)

Lung cancer (Amsterdam, Netherlands), 2008-05, Vol.60 (2), p.259-263

2008

Volltextzugriff (PDF)

Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression

Molecular cancer therapeutics, 2010-08, Vol.9 (8), p.2309-2321

2010

Volltextzugriff (PDF)

Reverse Signaling through Membrane-bound Interleukin-15

The Journal of biological chemistry, 2004-10, Vol.279 (40), p.42192-42201

2004

Volltextzugriff (PDF)

A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors

Molecular cancer therapeutics, 2005-06, Vol.4 (6), p.948-955

2005

Volltextzugriff (PDF)

Melanoma 2007: Current State and Preview of the Future

Seminars in oncology, 2007-12, Vol.34 (6), p.449-451

2007

Volltextzugriff (PDF)

An ERBB3/ERBB2 oncogenic unit plays a key role in NRG1 signaling and melanoma cell growth and survival

Pigment cell and melanoma research, 2013-05, Vol.26 (3), p.408-414

2013

Volltextzugriff (PDF)

Withdrawal: Suppression of NF-κB survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL

The Journal of biological chemistry, 2019-11, Vol.294 (48), p.18518-18518

2019

Volltextzugriff (PDF)

Interferon-stimulated genes and their protein products: what and how?

Journal of interferon & cytokine research, 2011-01, Vol.31 (1), p.1-4

2011

Volltextzugriff (PDF)

1 – 25 von 284

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(266)
Mit Volltextzugriff
(233)

Publikationsform

Artikel
(279)
Reviews
(4)
Sonstige
(1)

Sprache

Englisch
(284)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interferons α and β in cancer: therapeutic opportunities from new insights

Interferons at age 50: past, current and future impact on biomedicine

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group

Emerging roles of FAM14 family members (G1P3/ISG 6-16 and ISG12/IFI27) in innate immunity and cancer

Noncanonical Activation of Notch1 Protein by Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Controls Melanoma Cell Proliferation

Phase II Study of Erlotinib in Patients With Malignant Pleural Mesothelioma: A Southwest Oncology Group Study

Interferons and Their Stimulated Genes in the Tumor Microenvironment

Proteomic identification of proteins conjugated to ISG15 in mouse and human cells

Phase I trials of targeted anticancer drugs: a need to refocus

Overcoming Resistance to Interferon-Induced Apoptosis of Renal Carcinoma and Melanoma Cells by DNA Demethylation

G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells

Identification of X-linked Inhibitor of Apoptosis-associated Factor-1 as an Interferon-stimulated Gene That Augments TRAIL Apo2L-induced Apoptosis

Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands

Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma

The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon

Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: A phase II study of the Southwest Oncology Group (SWOG 9810)

Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression

Reverse Signaling through Membrane-bound Interleukin-15

A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors

Melanoma 2007: Current State and Preview of the Future

Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033

An ERBB3/ERBB2 oncogenic unit plays a key role in NRG1 signaling and melanoma cell growth and survival

Withdrawal: Suppression of NF-κB survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL

Interferon-stimulated genes and their protein products: what and how?

Suchergebnisse filtern